Stay updated on PRS-343 & Atezolizumab in HER2+ Solid Tumors Clinical Trial

Sign up to get notified when there's something new on the PRS-343 & Atezolizumab in HER2+ Solid Tumors Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the PRS-343 & Atezolizumab in HER2+ Solid Tumors Clinical Trial page

  1. Check
    4 days ago
    No Change Detected
  2. Check
    11 days ago
    Change Detected
    Summary
    Revision: v3.6.4 replaces v3.6.3 on the page, reflecting a minor metadata update. This does not change the study content or visible details.
    Difference
    0.1%
    Check dated 2026-07-28T03:05:59.000Z thumbnail image
  3. Check
    18 days ago
    No Change Detected
  4. Check
    25 days ago
    No Change Detected
  5. Check
    33 days ago
    Change Detected
    Summary
    Footer revision stamp updated from v3.6.2 to v3.6.3. This reflects a page template revision and does not alter the study details displayed.
    Difference
    0.1%
    Check dated 2026-07-06T18:12:01.000Z thumbnail image
  6. Check
    40 days ago
    Change Detected
    Summary
    The page's revision tag was updated from v3.6.0 to v3.6.2, indicating a new version of the ClinicalTrials.gov page rather than a substantive change to the study details.
    Difference
    0.1%
    Check dated 2026-06-29T13:49:40.000Z thumbnail image
  7. Check
    54 days ago
    Change Detected
    Summary
    The page now indicates that recruitment has ended ('No longer looking for participants'), and there are minor navigational/formatting updates (the Intervention/Treatment heading formatting, newly added help sections such as 'How to Read a Study Record', 'Common Questions', 'How to Join a Study', and an updated revision tag from v3.5.5 to v3.6.0).
    Difference
    0.4%
    Check dated 2026-06-15T08:15:02.000Z thumbnail image
  8. Check
    61 days ago
    Change Detected
    Summary
    The page revision label was updated from v3.5.4 to v3.5.5, reflecting a minor maintenance update to the site's versioning for this page. No study content or data is altered.
    Difference
    0.1%
    Check dated 2026-06-08T04:11:51.000Z thumbnail image
  9. Check
    83 days ago
    Change Detected
    Summary
    Revision updated from v3.5.3 to v3.5.4, indicating a new page release in the system. The change does not alter the visible content or study data on the page.
    Difference
    0.1%
    Check dated 2026-05-17T09:41:33.000Z thumbnail image

Stay in the know with updates to PRS-343 & Atezolizumab in HER2+ Solid Tumors Clinical Trial

Enter your email address, and we'll notify you when there's something new on the PRS-343 & Atezolizumab in HER2+ Solid Tumors Clinical Trial page.